Novartis India News

Amitabh Dube, Country President and Managing Director of Novartis India, has been appointed as the new president of OPPI for a two-year term. Dube brings nearly

Karan Bhagat, CEO of 360 One Group, purchased 1.3 lakh shares of Novartis India for approximately Rs 22 crore, while his firm Kyrush Investments sold an equal n

Novartis India is set to acquire the Minipress and Minipres trademarks and related intellectual property from Pfizer for approximately ₹1,250 crore.

Novartis India shares surged 4% after its board approved the acquisition of Pfizer trademarks for ₹1,250 crore, with an agreement executed on September 7.

Novartis India announced plans for therapy-aligned acquisitions and deeper market penetration, focusing on five key therapy areas for expansion. The company aim

Dr. Reddy's and Novartis India have terminated their agreement, leading to Novartis India re-acquiring exclusivity and market access for products previously pro

ChrysCapital has acquired a controlling 70.68% stake in Novartis India Limited, marking its first majority investment in India's pharmaceutical sector. The comp

ChrysCapital has acquired a controlling stake in Novartis India, marking its first majority-controlled investment in the Indian pharmaceutical sector, and has a